Analisi dei consumi di due classi di medicinali biotecnologici (ESA e G-CSF) in cinque Paesi europei

Autor:	P. Musto, F. De Ferrari, Roberto Ravasio, Franco Locatelli
Rok vydání:	2013
Předmět:	Competition (economics) business.industry Health Policy Medicine Pharmacology (medical) Biosimilar International trade business health care economics and organizations
Zdroj:	PharmacoEconomics Italian Research Articles. 15:9-17
ISSN:	2035-6137 1590-9158
Popis:	The expected benefits of biosimilar drugs (a lower price and a competition effect on originators’ price) offer an opportunity to contain the rising trend of the hospital pharmaceutical expenditure. This paper reviews the characteristics of biotechnological products and their regulatory features with the aim to evaluate if and how biosimilars are substituting the originators in the respective markets.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdf78bddfee84391326d63ec9ac391cf https://doi.org/10.1007/s40276-013-0002-6 Zobrazit plný text záznamu Full text from SpringerLink